Neuroblastoma
Neuroblastoma is an embryonal tumour of sympathetic neural-crest tissue, usually adrenal or paraspinal, with behaviour ranging from spontaneous regression in selected infants to aggressive metastatic disease; a child with an abdominal mass and systemic or neurological features needs urgent specialist assessment.
In a nutshell
Neuroblastoma is a sympathetic neural-crest tumour, often adrenal or paraspinal. A child may have an abdominal mass that crosses the midline, systemic upset, bone pain, limp, pallor, periorbital bruising, Horner syndrome or opsoclonus-myoclonus. Urinary VMA/HVA, specialist cross-sectional and functional imaging, marrow assessment and MYCN biology support staging. Spinal cord compression is an emergency. Treatment ranges from specialist observation or surgery for selected low-risk disease to intensive multimodal treatment for high-risk disease.
Classic presentation
A toddler is unwell with a firm abdominal mass, pallor, weight loss, bone pain and periorbital bruising. Refer very urgently; if gait, bladder or neurological function is changing, escalate immediately for possible cord compression.
Key points
- Neuroblastoma arises from sympathetic tissue, commonly adrenal or paraspinal.
- An abdominal mass may cross the midline or encase vessels; the child is often systemically unwell.
- Bone or marrow spread causes pain, limp, pallor and periorbital bruising.
- Urinary VMA/HVA support the diagnosis; MYCN amplification is an adverse biological feature.
- Paraspinal extension can cause spinal cord compression and needs immediate specialist escalation.
- Stage MS disease in infants can regress or mature, so treatment is risk- and symptom-directed.
First-line investigation
Urgent clinical assessment and abdominal ultrasound alongside very urgent specialist referral; specialist teams then use cross-sectional/functional imaging and tumour biology.
Management
Refer and look for emergencies
Define site and spread
- Use specialist cross-sectional and functional imaging, urinary catecholamines, marrow assessment and tumour biology to assign risk.1
Treat by risk group
- Observation or surgery may suit selected low-risk disease; high-risk disease needs protocol-led multimodal treatment and immunotherapy.1
Monitor relapse and late effects
- Follow relapse, growth, endocrine, cardiac, hearing, renal, fertility, neurocognitive and psychosocial outcomes through the specialist service.1
Exam traps
- Neuroblastoma may cross the midline; Wilms tumour is the main renal-mass differential.
- Normal catecholamine metabolites do not exclude neuroblastoma.
- Periorbital bruising can be metastatic neuroblastoma, not simply trauma.
- Horner syndrome or opsoclonus-myoclonus may be the presenting clue.
- Do not observe a suspected tumour outside a specialist risk-stratified pathway.
Key sources
- CCLG, Neuroblastoma in children (UK specialist cancer information covering symptoms, spread, investigations, stage MS disease, risk-directed treatment, immunotherapy, retinoid therapy, current DFMO access caveat and follow-up; accessed 4 August 2026)
- CCLG Child Cancer Smart, Abdominal tumours (UK professional decision-support tool for 0- to 18-year-olds with possible abdominal tumour; current page accessed 4 August 2026)
- NICE NG12, Suspected cancer: recognition and referral (NICE guideline current page last updated 15 April 2026; very urgent referral within 48 hours for palpable abdominal mass or unexplained enlarged abdominal organ in a child)Updated 15 Apr 2026
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

